On this page
In Australia, publication of a study, overseas approval and inclusion in the Australian Register of Therapeutic Goods (ARTG) are different events. A product marketed online does not become approved because its ingredient is being studied or because the label says “research use only.”
Five statuses readers commonly confuse
| Status | What it means | What it does not mean |
|---|---|---|
| Preclinical research | Laboratory or animal investigation. | Human safety, efficacy or approval. |
| Registered clinical trial | A protocol is recorded and authorised through relevant governance. | Positive results or general commercial supply. |
| Overseas approval | A regulator in another country approved a defined product and indication. | Automatic Australian approval. |
| ARTG inclusion | A therapeutic good is entered in Australia’s register under a defined sponsor and purpose. | That every product with the same ingredient is equivalent. |
| Unapproved-goods access pathway | A legal pathway may permit access in specific circumstances. | General approval or unrestricted advertising. |
The ARTG is product-specific
An ARTG entry identifies a sponsor, product, dosage form, strength or other particulars and intended purpose. Ingredient-name similarity does not prove that an online vial belongs to that entry.
Clinical trials are controlled access
Clinical-trial material is manufactured, labelled, stored and used under a protocol with ethics, safety and accountability controls. A commercial product outside the trial is not made legitimate by citing the trial.
Unapproved access is not approval
The TGA describes pathways such as the Special Access Scheme, Authorised Prescriber scheme and clinical-trial arrangements. These have eligibility, practitioner, reporting and governance requirements. They are not retail loopholes.
“Research use only” is not a regulatory shield
Regulatory treatment follows actual intended purpose, presentation, claims, supply and use—not a disclaimer in isolation. Therapeutic claims can bring a product and its advertising within therapeutic-goods law.
A practical verification workflow
- Search the exact name and sponsor in the ARTG.
- Open the entry and match formulation, strength, presentation and indication.
- Check current TGA safety alerts and recalls.
- For trials, open the live registry record and identify sponsor, sites and status.
- Do not infer legality or identity from a seller’s certificate alone.
Sources
- TGA: Australian Register of Therapeutic Goods
- TGA: access to unapproved therapeutic goods
- TGA: clinical trials
Editorial note: General regulatory information, not legal or medical advice. Verify current TGA records for a specific case.
How to cite this article
ARTG, Unapproved Therapeutic Goods and Clinical Trials: An Australian Reader’s Guide. Elite Peps Australia. Published 14 September 2026; updated 14 September 2026. https://elitepepsaustralia.com/artg-unapproved-therapeutic-goods-clinical-trials-australia/
Source checks: Consult the primary studies, trial records and regulator documents linked in this article for current evidence and status. Publication and update dates do not by themselves indicate an evidence review.